Advisors Management Group’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$6.14M Sell
51,089
-7,536
-13% -$870K 1.12% 23
2025
Q4
$6.17M Sell
58,625
-10,482
-15% -$984K 1.12% 25
2025
Q3
$5.8M Buy
69,107
+2,167
+3% +$178K 1.02% 30
2025
Q2
$5.3M Buy
66,940
+44,523
+199% +$3.54M 1% 31
2025
Q1
$2.01M Buy
22,417
+514
+2% +$48K 0.44% 60
2024
Q4
$2.18M Sell
21,903
-136
-0.6% -$14K 0.52% 59
2024
Q3
$2.5M Buy
22,039
+68
+0.3% +$8.08K 0.59% 56
2024
Q2
$2.72M Sell
21,971
-213
-1% -$27.4K 0.68% 51
2024
Q1
$2.93M Sell
22,184
-265
-1% -$32.7K 0.73% 45
2023
Q4
$2.45M Sell
22,449
-97
-0.4% -$10.1K 0.66% 50
2023
Q3
$2.32M Sell
22,546
-228
-1% -$24.6K 0.7% 51
2023
Q2
$2.63M Sell
22,774
-265
-1% -$30.1K 0.78% 43
2023
Q1
$2.45M Sell
23,039
-51
-0.2% -$5.51K 0.78% 45
2022
Q4
$2.56M Sell
23,090
-83
-0.4% -$8.48K 0.97% 37
2022
Q3
$2M Buy
23,173
+277
+1% +$24.7K 0.79% 46
2022
Q2
$2.09M Buy
22,896
+20,117
+724% +$1.78M 0.73% 46
2022
Q1
$228K Buy
+2,779
New +$219K 0.08% 117

Other funds holding MRK

Advisors Management Group's MRK Position: Q1 2026 in Review

Advisors Management Group reduced its Merck (MRK) stake by 13% in Q1 2026, selling an estimated $870K and leaving 51,089 shares worth $6.14M. The position accounts for 1.12% of the portfolio, ranked #23.

Advisors Management Group first reported a position in MRK in Q1 2022 and has held it in 17 quarters since. The position peaked at $6.17M in Q4 2025. 3,775 funds tracked by Wall St. Rank hold MRK as of Q1 2026.

  • Advisors Management Group held 51,089 shares of Merck worth $6.14M as of Q1 2026.
  • Advisors Management Group sold 7,536 Merck shares in Q1 2026, an estimated $870K.
  • Merck made up 1.12% of Advisors Management Group's portfolio in Q1 2026, its #23 holding.
  • Advisors Management Group first reported a position in Merck in Q1 2022 and has held it in 17 quarters since.
  • Advisors Management Group's Merck position peaked at $6.17M in Q4 2025.
  • 3,775 funds tracked by Wall St. Rank held Merck as of Q1 2026.

Based on Advisors Management Group's 13F filing for Q1 2026, filed 1 May 2026.